PMID- 32997881 OWN - NLM STAT- MEDLINE DCOM- 20210430 LR - 20220727 IS - 1399-3062 (Electronic) IS - 1398-2273 (Print) IS - 1398-2273 (Linking) VI - 23 IP - 2 DP - 2021 Apr TI - COVID-19 in a lung transplant recipient: Exploring the diagnostic role of circulating exosomes and the clinical impact of advanced immunosuppression. PG - e13480 LID - 10.1111/tid.13480 [doi] LID - e13480 AB - Exosomes isolated from plasma of lung transplant recipients with allograft injury contain donor-derived lung self-antigens (collagen V and Kalpha1 tubulin) and human leukocyte antigen (HLA) molecules. We present a case of a 76-year-old, female lung transplant recipient treated for acute cellular rejection with methylprednisolone and anti-thymocyte globulin, who subsequently contracted SARS-CoV-2 and developed a sharp increase in the mean fluorescent intensity of anti-HLA antibodies. Analysis of circulating exosomes during rejection, but before SARS-CoV-2 infection, revealed the presence of lung self-antigens and HLA class II molecules. After the patient contracted SARS-CoV-2, exosomes with the SARS-CoV-2 spike protein were also found. After resolution of infectious symptoms, exosomes with SARS-CoV-2 spike protein were no longer detected; however, exosomes with lung self-antigens and HLA class II molecules persisted, which coincided with a progressive decline in spirometric flows, suggesting chronic lung allograft dysfunction. We propose that the analysis of circulating exosomes may be used to detect allograft injury mediated by both rejection and infection. Furthermore, the detection of exosomes containing viral proteins may be helpful in identifying allograft injury driven by viral pathogens. CI - (c) 2020 Wiley Periodicals LLC. FAU - Goodlet, Kellie J AU - Goodlet KJ AUID- ORCID: 0000-0002-9736-0891 AD - Department of Pharmacy Practice, College of Pharmacy, Midwestern University, Glendale, AZ, USA. FAU - Bansal, Sandhya AU - Bansal S AD - Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. FAU - Arjuna, Ashwini AU - Arjuna A AUID- ORCID: 0000-0002-4171-3184 AD - Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. FAU - Nailor, Michael D AU - Nailor MD AD - Department of Pharmacy Services, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. FAU - Buddhdev, Bhuvin AU - Buddhdev B AD - Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. FAU - Abdelrazek, Hesham AU - Abdelrazek H AD - Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. FAU - Mohamed, Hesham AU - Mohamed H AD - Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. FAU - Omar, Ashraf AU - Omar A AD - Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. FAU - Walia, Rajat AU - Walia R AD - Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. FAU - Mohanakumar, Thalachallour AU - Mohanakumar T AUID- ORCID: 0000-0001-9873-4018 AD - Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. FAU - Tokman, Sofya AU - Tokman S AUID- ORCID: 0000-0003-2821-8776 AD - Norton Thoracic Institute, Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. LA - eng GR - R01 HL056643/HL/NHLBI NIH HHS/United States GR - HL056643/NH/NIH HHS/United States PT - Case Reports DEP - 20201013 PL - Denmark TA - Transpl Infect Dis JT - Transplant infectious disease : an official journal of the Transplantation Society JID - 100883688 RN - 0 (Antilymphocyte Serum) RN - 0 (Autoantigens) RN - 0 (Collagen Type V) RN - 0 (Glucocorticoids) RN - 0 (HLA Antigens) RN - 0 (Histocompatibility Antigens Class II) RN - 0 (Immunosuppressive Agents) RN - 0 (Spike Glycoprotein, Coronavirus) RN - 0 (Tubulin) RN - 0 (spike protein, SARS-CoV-2) RN - X4W7ZR7023 (Methylprednisolone) SB - IM MH - Aged MH - Antilymphocyte Serum/therapeutic use MH - Autoantigens/immunology/metabolism MH - Bronchiolitis Obliterans MH - COVID-19/immunology/*metabolism MH - Collagen Type V/immunology/metabolism MH - Disease Progression MH - Exosomes/*metabolism MH - Female MH - Glucocorticoids/adverse effects/therapeutic use MH - Graft Rejection/*drug therapy MH - HLA Antigens/immunology/metabolism MH - Histocompatibility Antigens Class II/immunology/*metabolism MH - Humans MH - Immunosuppressive Agents/*adverse effects/therapeutic use MH - *Lung Transplantation MH - Methylprednisolone/adverse effects/therapeutic use MH - SARS-CoV-2/immunology/metabolism MH - Spike Glycoprotein, Coronavirus/immunology/*metabolism MH - Tubulin/immunology/metabolism PMC - PMC7536938 OTO - NOTNLM OT - COVID-19 OT - allograft dysfunction OT - exosomes OT - lung self antigens OT - lung transplant OT - rejection COIS- The authors of this manuscript have no disclosures to report. EDAT- 2020/10/01 06:00 MHDA- 2021/05/01 06:00 PMCR- 2020/10/13 CRDT- 2020/09/30 17:13 PHST- 2020/09/10 00:00 [received] PHST- 2020/09/20 00:00 [accepted] PHST- 2020/10/01 06:00 [pubmed] PHST- 2021/05/01 06:00 [medline] PHST- 2020/09/30 17:13 [entrez] PHST- 2020/10/13 00:00 [pmc-release] AID - TID13480 [pii] AID - 10.1111/tid.13480 [doi] PST - ppublish SO - Transpl Infect Dis. 2021 Apr;23(2):e13480. doi: 10.1111/tid.13480. Epub 2020 Oct 13.